Literature DB >> 27496047

Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.

Orsolya Jójárt-Laczkovich1, Gábor Katona2, Zoltán Aigner3, Piroska Szabó-Révész3.   

Abstract

The aim of this work was an investigation of the physical changes of the amorphous model material spray-dried trehalose through the use of various analytical techniques and to identify a suitable, rapid method able to quantify the changes. The crystallinity changes and recrystallization process of amorphous samples were investigated by hot-humidity stage X-ray powder diffractometry (HH-XRPD) with fresh samples, conventional X-ray powder diffractometry (XRPD) used stored samples and by differential scanning calorimetry (DSC). The data from the three methods were compared and the various forms of trehalose were analysed. HH-XRPD demonstrated that the recrystallization began at 40 and 60°C up to 45% RH and at 70°C up to 30% RH into dihydrate form. At 70°C up to 60% RH the anhydrous form of trehalose appeared too. Conventional XRPD results showed, that in the 28days stored samples the dihydrate form was detected at 40°C, 50% RH. Storage at 60°C, 40% RH resulted in the appearance of the anhydrous form and at 60°C, 50% RH both polymorphic forms were detected. By carrying out the DSC measurements at different temperatures the fraction of recrystallized trehalose dihydrate was detected. The recrystallization investigated by HH-XRPD and DSC followed Avrami kinetics, the calculated rate constants of isothermal crystallization (K) were same. Both HH-XRPD and conventional XRPD was suitable for the detection of the physical changes of the amorphous model material. DSC measurements showed similar results as HH-XRPD. Primarily HH-XRPD could be suggested for prediction, because the method is fast and every changes could be studied on one sample. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Activation energy; DSC; Hot-humidity stage XRPD; Recrystallization; Trehalose

Mesh:

Substances:

Year:  2016        PMID: 27496047     DOI: 10.1016/j.ejps.2016.08.003

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  1 in total

1.  Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia.

Authors:  Csaba Bartos; Rita Ambrus; Gábor Katona; Tamás Sovány; Róbert Gáspár; Árpád Márki; Eszter Ducza; Anita Ivanov; Ferenc Tömösi; Tamás Janáky; Piroska Szabó-Révész
Journal:  Drug Des Devel Ther       Date:  2019-11-28       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.